BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2444245)

  • 1. The haematology of steady state homozygous sickle cell disease: interrelationships between haematological indices.
    Maude GH; Hayes RJ; Serjeant GR
    Br J Haematol; 1987 Aug; 66(4):549-58. PubMed ID: 2444245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle cell-hereditary persistence of fetal haemoglobin and its differentiation from other sickle cell syndromes.
    Murray N; Serjeant BE; Serjeant GR
    Br J Haematol; 1988 May; 69(1):89-92. PubMed ID: 2454649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The haematology of steady state homozygous sickle cell disease: frequency distributions, variation with age and sex, longitudinal observations.
    Hayes RJ; Beckford M; Grandison Y; Mason K; Serjeant BE; Serjeant GR
    Br J Haematol; 1985 Feb; 59(2):369-82. PubMed ID: 2578806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of homozygous sickle cell disease in northern Greece and Jamaica.
    Christakis J; Vavatsi N; Hassapopoulou H; Papadopoulou M; Mandraveli K; Loukopoulos D; Morris JS; Serjeant BE; Serjeant GR
    Lancet; 1990 Mar; 335(8690):637-40. PubMed ID: 1690325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determinants of irreversibly sickled cells in homozygous sickle cell disease.
    Serjeant GR; Serjeant BE; Desai P; Mason KP; Sewell A; England JM
    Br J Haematol; 1978 Nov; 40(3):431-8. PubMed ID: 749928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell disease in Orissa State, India.
    Kar BC; Satapathy RK; Kulozik AE; Kulozik M; Sirr S; Serjeant BE; Serjeant GR
    Lancet; 1986 Nov; 2(8517):1198-201. PubMed ID: 2430154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell anaemia in Nigeria: a comparison between Benin and Lagos.
    Akenzua G; Akinyanju O; Kulozik A; Whitehead S; Morris J; Serjeant BE; Serjeant G
    Afr J Med Med Sci; 1994 Jun; 23(2):101-7. PubMed ID: 7542830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematological study in sickle cell homozygous and heterozygous children in the age group 0-6 years.
    Walke VA; Walde MS
    Indian J Pathol Microbiol; 2007 Oct; 50(4):901-4. PubMed ID: 18306601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematological change in sickle cell-haemoglobin C disease and in sickle cell-beta thalassaemia: a cohort study from birth.
    Stevens MC; Maude GH; Beckford M; Grandison Y; Mason K; Serjeant BE; Taylor B; Topley JM; Serjeant GR
    Br J Haematol; 1985 Jun; 60(2):279-92. PubMed ID: 4005180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclassification of HbS syndrome: is it necessary?
    Tyagi S; Choudhry VP; Saxena R
    Clin Lab Haematol; 2003 Dec; 25(6):377-81. PubMed ID: 14641142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between foetal haemoglobin and haematological indices in children with sickle cell anaemia from South Western Nigeria.
    Akinlosotu MA; Adegoke SA; Oseni SB; Adeodu OO
    Niger Postgrad Med J; 2017; 24(4):195-200. PubMed ID: 29355156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red cell size and the clinical and haematological features of homozygous sickle cell disease.
    Serjeant GR; Foster K; Serjeant BE
    Br J Haematol; 1981 Jul; 48(3):445-9. PubMed ID: 6167280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of haemoglobin level in steady-state homozygous sickle cell disease.
    Serjeant G; Serjeant B; Stephens A; Roper D; Higgs D; Beckford M; Cook J; Thomas P
    Br J Haematol; 1996 Jan; 92(1):143-9. PubMed ID: 8562387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
    Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting prepubertal growth in homozygous sickle cell disease.
    Singhal A; Morris J; Thomas P; Dover G; Higgs D; Serjeant G
    Arch Dis Child; 1996 Jun; 74(6):502-6. PubMed ID: 8758125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Couples With MCV≥80, MCH<26, HbA2<3.2, HbF<3 be Classified as Low-risk β-Thalassemia Group?
    Mirzakhani M; Tarrahi MJ; Baghersad A; Maracy MR
    J Pediatr Hematol Oncol; 2019 May; 41(4):303-306. PubMed ID: 30676434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of sickle-cell anemia based on a profile of hematological variables.
    Odenheimer DJ; Whitten CF; Rucknagel DL; Sarnaik SA; Sing CF
    Am J Hum Genet; 1983 Nov; 35(6):1224-40. PubMed ID: 6196966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematological factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease.
    Hawker H; Neilson H; Hayes RJ; Serjeant GR
    Br J Haematol; 1982 Jan; 50(1):29-34. PubMed ID: 6173057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume regulation and KCl cotransport in reticulocyte populations of sickle and normal red blood cells.
    Quarmyne MO; Risinger M; Linkugel A; Frazier A; Joiner C
    Blood Cells Mol Dis; 2011 Aug; 47(2):95-9. PubMed ID: 21576026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.
    Ballas SK; McCarthy WF; Guo N; Brugnara C; Kling G; Bauserman RL; Waclawiw MA
    Hemoglobin; 2010; 34(5):424-9. PubMed ID: 20854115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.